General Information of the Compound
Compound ID
CP0439496
Compound Name
4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol
    Show/Hide
Synonyms
4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol
    Show/Hide
Structure
Formula
C20H15ClN2O
Molecular Weight
334.806
Canonical SMILES
Oc1ccc(cc1)-c1nn(Cc2ccccc2)c2c(Cl)cccc12
    Show/Hide
InChI
InChI=1S/C20H15ClN2O/c21-18-8-4-7-17-19(15-9-11-16(24)12-10-15)22-23(20(17)18)13-14-5-2-1-3-6-14/h1-12,24H,13H2
    Show/Hide
InChIKey
DPRKSCQCEZRMAF-UHFFFAOYSA-N
Physicochemical Property
logP
5.1106
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
38.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135503667
SID: 15075214
ChEMBL ID
CHEMBL221626
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00886, Estrogen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000622 HAECT-1 Homo sapiens (Human)  2
1
EC50 = 390 nM
   TI
   LI
   LO
   TS
2
IC50 = 105 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol )
Drug Name 4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol
Target(s)
Estrogen receptor (ESR)
Inhibitor